Decay-Accelerating Factor Differentially Associates With Complement-Mediated Damage in Synovium After Meniscus Tear as Compared to Anterior Cruciate Ligament Injury

키워드

참고문헌 (48)

1. Brown TD, "Posttraumatic osteoarthritis : a first estimate of incidence, prevalence, and burden of disease", J Orthop Trauma, 20, pp.739~744 (2006)
2. Hsia AW, "Post-traumatic osteoarthritis progression is diminished by early mechanical unloading and anti-inflammatory treatment in mice", Osteoarthritis Cartilage, 29, pp.1709~1719 (2021)
3. Dare D, "Mechanisms of post-traumatic osteoarthritis after ACL injury", Curr Rheumatol Rep, 16, pp.448~ (2014)
4. Lohmander LS, "The long-term consequence of anterior cruciate ligament and meniscus injuries : osteoarthritis", Am J Sports Med, 35, pp.1756~1769 (2007)
5. Racine J, "Post-traumatic osteoarthritis after ACL injury", R I Med J(2013), 97, pp.25~28 (2014)
6. Wang LJ, "Post-traumatic osteoarthritis following ACL injury", Arthritis Res Ther, 22, pp.57~ (2020)
7. Ratzlaff CR, "New developments in osteoarthritis. Prevention of injury-related knee osteoarthritis : opportunities for the primary and secondary prevention of knee osteoarthritis", Arthritis Res Ther, 12, pp.215~ (2010)
8. Holers VM, "Potential causal role of synovial complement system activation in the development of post-traumatic osteoarthritis after anterior cruciate ligament injury or meniscus tear", Front Immunol, 14, pp.1146563~ (2023)
9. Toomey CB, "The role of decay accelerating factor in environmentally induced and idiopathic systemic autoimmune disease", Autoimmune Dis, 2014, pp.452853~ (2014)
10. Frank MM, "Stiehm’s Immune Deficiencies", pp.731~763 (2014), Academic Press
11. Medof ME, "Identification of the complement decay-accelerating factor(DAF)on epithelium and glandular cells and in body fluids", J Exp Med, 165, pp.848~864 (1987)
12. Lukacik P, "Complement regulation at the molecular level : the structure of decay-accelerating factor", Proc Natl Acad Sci U S A, 101, pp.1279~1284 (2004)
13. Hamann J, "The seven-span transmembrane receptor CD97 has a cellular ligand(CD55, DAF)", J Exp Med, 184, pp.1185~1189 (1996)
14. Karpus ON, "Triggering of the dsRNA sensors TLR3, MDA5, and RIG-I induces CD55 expression in synovial fibroblasts", PLoS One, 7, pp.e35606~ (2012)
15. Nicholson-Weller A, "Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b, 2a", J Immunol, 127, pp.2035~2039 (1981)
16. Pangburn MK, "Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria", Proc Natl Acad Sci U S A, 80, pp.5430~5434 (1983)
17. Medof ME, "Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor(DAF)into their membranes", J Exp Med, 160, pp.1558~1578 (1984)
18. Lublin DM, "Decay-accelerating factor : biochemistry, molecular biology, and function", Annu Rev Immunol, 7, pp.35~58 (1989)
19. Geller A, "The role of membrane bound complement regulatory proteins in tumor development and cancer immunotherapy", Front Immunol, 10, pp.1074~ (2019)
20. Dho SH, "Beyond the role of CD55 as a complement component", Immune Netw, 18, pp.e11~ (2018)
21. Naraoka T, "Time-dependent gene expression and immunohistochemical analysis of the injured anterior cruciate ligament", Bone Joint Res, 1, pp.238~244 (2012)
22. Karpus ON, "CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis", Arthritis Res Ther, 17, pp.6~ (2015)
23. Tarkowski A, "Expression of decay-accelerating factor on synovial lining cells in inflammatory and degenerative arthritides", Rheumatol Int, 12, pp.201~205 (1992)
24. Krenn V, "15 Years of the histopathological synovitis score, further development and review : a diagnostic score for rheumatology and orthopaedics", Pathol Res Pract, 213, pp.874~881 (2017)
25. Banda NK, "Analysis of complement gene expression, clinical associations, and biodistribution of complement proteins in the synovium of early rheumatoid arthritis patients reveals unique pathophysiologic features", J Immunol, 208, pp.2482~2496 (2022)
26. Nasu J, "Cytokine-stimulated release of decay-accelerating factor(DAF;CD55)from HT-29 human intestinal epithelial cells", Clin Exp Immunol, 113, pp.379~385 (1998)
27. Cocuzzi ET, "Upregulation of DAF(CD55)on orbital fibroblasts by cytokines. Differential effects of TNF-beta and TNF-alpha", Curr Eye Res, 23, pp.86~92 (2001)
28. Cuellar VG, "Cytokine profiling in acute anterior cruciate ligament injury", Arthroscopy, 26, pp.1296~1301 (2010)
29. Bigoni M, "Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee", J Orthop Res, 35, pp.340~346 (2017)
30. Spiller OB, "Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack", Clin Exp Immunol, 121, pp.234~241 (2000)
31. Martel-Pelletier J, "The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function", Arthritis Rheum, 35, pp.530~540 (1992)
32. Sadouk MB, "Human synovial fibroblasts coexpress IL-1 receptor type I and type II mRNA. The increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor", Lab Invest, 73, pp.347~355 (1995)
33. Sellam J, "The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis", Nat Rev Rheumatol, 6, pp.625~635 (2010)
34. Loeser RF, "Osteoarthritis : a disease of the joint as an organ", Arthritis Rheum, 64, pp.1697~1707 (2012)
35. Henderson B, "Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit : evidence for synergistic interactions between cytokines in vivo", Clin Exp Immunol, 75, pp.306~310 (1989)
36. Berger M, "Increased expression of complement decay-accelerating factor during activation of human neutrophils", J Clin Invest, 79, pp.214~220 (1987)
37. Wang Q, "Identification of a central role for complement in osteoarthritis", Nat Med, 17, pp.1674~1679 (2011)
38. Liu J, "The complement inhibitory protein DAF(CD55)suppresses T cell immunity in vivo", J Exp Med, 201, pp.567~577 (2005)
39. Fridkis-Hareli M, "The human complement receptor type 2(CR2)", CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models, 2019, pp.105, 150~164
40. Ozen A, "CD55 deficiency, early-onset protein-losing enteropathy, and thrombosis", N Engl J Med, 377, pp.52~61 (2017)
41. Egan ES, "Malaria. A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion", Science, 348, pp.711~714 (2015)
42. Thurman JM, "All things complement", Clin J Am Soc Nephrol, 11, pp.1856~1866 (2016)
43. Li Q, "Augmenting DAF levels in vivo ameliorates experimental autoimmune encephalomyelitis", Mol Immunol, 46, pp.2885~2891 (2009)
44. Hamann J, "Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue", Arthritis Rheum, 42, pp.650~658 (1999)
45. Hill A, "Paroxysmal nocturnal haemoglobinuria", Nat Rev Dis Primers, 3, pp.17028~ (2017)
46. van den Wijngaard RM, "Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo", Br J Dermatol, 146, pp.80~87 (2002)
47. Qiao P, "Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid", Oncotarget, 9, pp.35517~35527 (2018)
48. Bharti R, "CD55 in cancer : complementing functions in a non-canonical manner", Cancer Lett, 551, pp.215935~ (2022)

관련 논문AI추천